Henrietta, NY, United States of America

David A Hilborn

This inventor holds 11 USPTO granted patents. Top assignees: Eastman-Kodak Company, Johnson & Johnson Clinical Diagnostics, Inc., Nycomed Imaging as. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Hilborn. Retrieved from https://idiyas.com/inventor/david-a-hilborn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 1989-1998

Loading Chart...
11 patents (USPTO):Explore Patents

Title: David A. Hilborn: Innovator in Immunoreagents and Complexing Agents

Introduction

David A. Hilborn is a notable inventor based in Henrietta, NY (US), recognized for his contributions to the field of immunoreagents and complexing agents. With a total of 11 patents to his name, Hilborn has made significant advancements that have implications in therapeutic and diagnostic applications.

Latest Patents

Among his latest patents, Hilborn has developed targeting radioactive immunoreagents that comprise a metal radionuclide ion, a complexing agent with a specific structure, and an immunoreactive group covalently bonded to the complexing agent. This invention is particularly valuable in therapeutic and diagnostic imaging compositions and methods. Additionally, he has created immunoassay elements that utilize polymers containing vanadium IV (V+4) ions, designed for assaying ligands in a dry immunoassay analytical element.

Career Highlights

Throughout his career, David A. Hilborn has worked with prominent companies such as Eastman Kodak Company and Sterling Winthrop Inc. His work in these organizations has allowed him to develop innovative solutions that enhance the capabilities of immunoassay technologies.

Collaborations

Hilborn has collaborated with notable colleagues, including John L. Toner and Bruce J. Murray, contributing to a rich exchange of ideas and advancements in their respective fields.

Conclusion

David A. Hilborn's work in the development of immunoreagents and complexing agents showcases his innovative spirit and dedication to advancing scientific knowledge. His contributions continue to impact the fields of therapeutic and diagnostic applications significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…